These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30275015)

  • 21. Codon usage biases co-evolve with transcription termination machinery to suppress premature cleavage and polyadenylation.
    Zhou Z; Dang Y; Zhou M; Yuan H; Liu Y
    Elife; 2018 Mar; 7():. PubMed ID: 29547124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma.
    Felisiak-Goląbek A; Inaguma S; Kowalik A; Wasąg B; Wang ZF; Zięba S; Pięciak L; Ryś J; Kopczynski J; Sarlomo-Rikala M; Góźdź S; Lasota J; Miettinen M
    Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):40-45. PubMed ID: 29206715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. eRF1 mediates codon usage effects on mRNA translation efficiency through premature termination at rare codons.
    Yang Q; Yu CH; Zhao F; Dang Y; Wu C; Xie P; Sachs MS; Liu Y
    Nucleic Acids Res; 2019 Sep; 47(17):9243-9258. PubMed ID: 31410471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schlafen14 Impairs HIV-1 Expression in a Codon Usage-Dependent Manner.
    Valenzuela C; Saucedo S; Llano M
    Viruses; 2024 Mar; 16(4):. PubMed ID: 38675845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulatory G4 motif of the Kirsten ras (KRAS) gene is sensitive to guanine oxidation: implications on transcription.
    Cogoi S; Ferino A; Miglietta G; Pedersen EB; Xodo LE
    Nucleic Acids Res; 2018 Jan; 46(2):661-676. PubMed ID: 29165690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of multifaceted functions of codon usage in translation within the model beetle Tribolium castaneum.
    Whittle CA; Kulkarni A; Extavour CG
    DNA Res; 2019 Dec; 26(6):473-484. PubMed ID: 31922535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of codon usage on gene expression are promoter context dependent.
    Yang Q; Lyu X; Zhao F; Liu Y
    Nucleic Acids Res; 2021 Jan; 49(2):818-831. PubMed ID: 33410890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation Of Wild-Type Hras Suppresses The Earliest Stages Of Pancreatic Cancer.
    Weyandt J
    Redox Biol; 2015 Aug; 5():414. PubMed ID: 28162272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective forces and mutational biases drive stop codon usage in the human genome: a comparison with sense codon usage.
    Trotta E
    BMC Genomics; 2016 May; 17():366. PubMed ID: 27188984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.
    Salmaninejad A; Ghadami S; Dizaji MZ; Golchehre Z; Estiar MA; Zamani MR; Ebrahimzadeh-Vesal R; Nowroozi MR; Shakoori A
    Clin Lab; 2015; 61(7):749-59. PubMed ID: 26299074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation.
    Bentley C; Jurinka SS; Kljavin NM; Vartanian S; Ramani SR; Gonzalez LC; Yu K; Modrusan Z; Du P; Bourgon R; Neve RM; Stokoe D
    Biochem J; 2013 Jun; 452(2):313-20. PubMed ID: 23496764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation.
    Sheffels E; Sealover NE; Wang C; Kim DH; Vazirani IA; Lee E; M Terrell E; Morrison DK; Luo J; Kortum RL
    Sci Signal; 2018 Sep; 11(546):. PubMed ID: 30181243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma.
    Wan X; Liu R; Li Z
    Biomed Res Int; 2017; 2017():5356737. PubMed ID: 29349077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Codon usage bias affects α-amylase mRNA level by altering RNA stability and cytosine methylation patterns in
    Xing Y; Gong R; Xu Y; Liu K; Zhou M
    Can J Microbiol; 2020 Sep; 66(9):521-528. PubMed ID: 32259457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent KRAS codon 146 mutations in human colorectal cancer.
    Edkins S; O'Meara S; Parker A; Stevens C; Reis M; Jones S; Greenman C; Davies H; Dalgliesh G; Forbes S; Hunter C; Smith R; Stephens P; Goldstraw P; Nicholson A; Chan TL; Velculescu VE; Yuen ST; Leung SY; Stratton MR; Futreal PA
    Cancer Biol Ther; 2006 Aug; 5(8):928-32. PubMed ID: 16969076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Codon optimality, bias and usage in translation and mRNA decay.
    Hanson G; Coller J
    Nat Rev Mol Cell Biol; 2018 Jan; 19(1):20-30. PubMed ID: 29018283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.
    Vaughn CP; Zobell SD; Furtado LV; Baker CL; Samowitz WS
    Genes Chromosomes Cancer; 2011 May; 50(5):307-12. PubMed ID: 21305640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Yin and Yang of codon usage.
    Komar AA
    Hum Mol Genet; 2016 Oct; 25(R2):R77-R85. PubMed ID: 27354349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calmodulin and IQGAP1 activation of PI3Kα and Akt in KRAS, HRAS and NRAS-driven cancers.
    Nussinov R; Zhang M; Tsai CJ; Jang H
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2304-2314. PubMed ID: 29097261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.